https://www.ncbi.nlm.nih.gov/myncbi/ying.ma.1/bibliography/public/

https://orcid.org/0000-0003-3282-4410

近五年代表性成果：

1. Ma Y*, Li J, Wang H, Chiu Y, Kingsley CV, Fry D, Delaney SD, Wei SC, Zhang J, Maitra A, Yee C*.Combination of PD1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer. Gastroenterology. 2020 July;159(1):306–319. *通讯作者
2. Ma, Y*, Hao J*. Dedifferentiation of Epithelial Cells Incorporates Immune Reprogramming, Trends in Cell Biology, 2021 April;31(4):237-240. *通讯作者
3. Zhang J, Li,X, Lu Y, Wang G*, Ma Y*. Anoikis-Related Gene Signature for Prognostication of Pancreatic Adenocarcinoma: A Multi-Omics Exploration and Verification Study. Cancers 2023 Jun 11; 15(12),3146. *通讯作者
4. Ma Y*, Li X, Zhang J, Zhao X, Lu Y, Shen G, Wang G*, Liu H*, Hao J*. Integrating Tertiary Lymphoid Structure-Associated Genes into Computational Models to Evaluate Prognostication and Immune Infiltration in Pancreatic Cancer. Journal of leukocyte biology 2024.*通讯作者
5. 郝继辉，马莹，等。肿瘤免疫学，科学出版社。2024“十四五”普通高等教育规划教材。(主编)